Gerontechnology Evaluation Framework: Outcome Validation

November 24, 2023 updated by: Dr. Derek Yee-Tak Cheung, The University of Hong Kong
The project aims to validate the evaluation indicators applicability of 9 Gerontechnology Evaluation Frameworks. The outcome is the perceived importance of the evaluation indicators described in the 9 Evaluation Frameworks. Participants will be invited to complete a questionnaire indicating the importance of the outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is a cross-sectional survey. 165 to 300 participants will be recruited to complete a questionnaire. For each product theme that they are familiar with, they will rate anonymously the perceived importance of the evaluation indicators on a 5-point Likert scale, give reasons for their ratings and suggest revisions.

Participants will be recruited through convenience sampling in 3 subgroups, including (1) members of Gerontechnology Application and Testing Working Group under Gerontechnology Platform, (2) successful applicants of Innovation and Technology Fund for buying gerontechnology products under the 9 themes, and (3) visitors of Gerontech and Innovation Expo. It is expected that 35% participants will be recruited in subgroup 1, 5% in subgroup 2, and 60% in subgroup 3.

Gerontechnology Platform will invite (1) its members of Gerontechnology Application and Testing Working Group, who are the Users, Caregivers, Staff and Suppliers of gerontechnology products, to fill in the questionnaire online. 3 email reminders will be sent to remind them to complete the questionnaire. (2) The list of successful applicants of Innovation and Technology Fund who applied for the product themes covered in the 9 Evaluation Frameworks will be downloaded from the Social Welfare Department website and their Staff will be invited to fill in the questionnaire online. (3) In Gerontech and Innovation Expo, which is a local exhibition that provides a platform for stakeholders to discuss and collaborate for broader adoption of gerontechnology, research staff will approach all visitors of the Gerontechnology Platform booth. The visitors who fulfil the inclusion and exclusion criteria will be invited to complete the questionnaire.

To ensure the validity of their responses, they will only answer the questionnaire items of the themes they have known, have used, or are most interested. For each product theme that they are familiar with, they will rate anonymously the perceived importance of the evaluation indicators on a 5-point Likert scale, give reasons for their ratings and suggest revisions. Their voluntary written consent will be sought before they complete the questionnaire. Each questionnaire will take around 5 - 10 minutes.

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Stakeholders of gerontechnology in Hong Kong

Description

Inclusion Criteria:

  • People in one of these categories: Working or has worked in a social service setting for the elderly or person with disability (Staff), an elderly aged 60 or above (User), a person with physical or disability (User), an informal caregiver for an elderly or a person with disability (Caregiver), or belonging to a company/or that has developed or retailed gerontechnology products (Supplier)

Exclusion Criteria:

  • Unable to read or write in Chinese

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Staff
A cross-sectional survey will be conducted.
Participants will provide their opinions in a questionnaire
User
A cross-sectional survey will be conducted.
Participants will provide their opinions in a questionnaire
Caregiver
A cross-sectional survey will be conducted.
Participants will provide their opinions in a questionnaire
Supplier
A cross-sectional survey will be conducted.
Participants will provide their opinions in a questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of importance on indicators of fall prevention Framework
Time Frame: 3 months
The level of agreement on indicators of fall prevention Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of health monitoring Framework
Time Frame: 3 months
The level of agreement on indicators of health monitoring Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of transfer and lifting Framework
Time Frame: 3 months
The level of agreement on indicators of transfer and lifting Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of hygiene management Framework
Time Frame: 3 months
The level of agreement on indicators of hygiene management Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of communication Framework
Time Frame: 3 months
The level of agreement on indicators of communication Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of anti-wandering Framework
Time Frame: 3 months
The level of agreement on indicators of anti-wandering Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of air quality sensor Framework
Time Frame: 3 months
The level of agreement on indicators of air quality sensor Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of feeding tools Framework
Time Frame: 3 months
The level of agreement on indicators of feeding tools Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months
Degree of importance on indicators of cognitive training and stimulation Framework
Time Frame: 3 months
The level of agreement on indicators of cognitive training and stimulation Framework. The opinions will be categorized into four levels of consensus according to the central tendency, level of dispersion, and the rated level of importance (Shi et al., 2022). The consensus levels are defined as: very high consensus (median = 5, inter-quartile range (IQR) = 0, rating score of 4/5 ≥ 80%); high consensus (median = 5, IQR = 1, rating score of 4/5 ≥ 80%); moderate consensus (median = 4-5, IQR = 1, rating score 4/5 ≥ 75%), and low consensus (median ≤ 4, IQR ≤ 2, rating score 4/5 < 75%).
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2023

Primary Completion (Estimated)

January 1, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

November 17, 2023

First Submitted That Met QC Criteria

November 17, 2023

First Posted (Actual)

November 27, 2023

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 24, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Gerontechnology Outcome

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be available

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Technology

Clinical Trials on Doing questionnaire

Subscribe